Literature DB >> 9763412

Regulation of hepatic cytochrome P450 2C11 by transforming growth factor-beta, hepatocyte growth factor, and interleukin-11.

H Iber1, E T Morgan.   

Abstract

Injection of rats with bacterial lipopolysaccharide down-regulates P450 (P450) 2C11 (2C11) mRNA to about 20% of its control levels after only 6 hr, and this level is maintained for at least 48 hr. Although we and others have demonstrated that this effect may be at least partially mediated by the cytokines interleukin-1, interleukin-6, and tumor necrosis factor-alpha, as well as by glucocorticoids, the time courses and potencies of 2C11 repression by each single mediator suggested that no cytokine alone is responsible for the entire time course of 2C11 suppression during inflammation. Here, we show that transforming growth factor-beta, hepatocyte growth factor, and interleukin-11 are potent inhibitors of 2C11 expression. In all three cases, 0.1 ng/ml was enough to down-regulate 2C11 mRNA levels to 50% of control. Interleukin-8, a cytokine that is secreted during the acute phase response but does not influence the liver acute phase response, did not affect 2C11 expression. The various mediators have different time courses of 2C11 down-regulation, indicating that the roles of each may be different at different phases of the response.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9763412

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  5 in total

Review 1.  Repression of gene expression by oxidative stress.

Authors:  Y Morel; R Barouki
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

Review 2.  The role of intracellular signaling in insulin-mediated regulation of drug metabolizing enzyme gene and protein expression.

Authors:  Sang K Kim; Raymond F Novak
Journal:  Pharmacol Ther       Date:  2006-11-13       Impact factor: 12.310

3.  Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.

Authors:  Alison E Aitken; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2007-06-18       Impact factor: 3.922

4.  Abundance of Phase 1 and 2 Drug-Metabolizing Enzymes in Alcoholic and Hepatitis C Cirrhotic Livers: A Quantitative Targeted Proteomics Study.

Authors:  Bhagwat Prasad; Deepak Kumar Bhatt; Katherine Johnson; Revathi Chapa; Xiaoyan Chu; Laurent Salphati; Guangqing Xiao; Caroline Lee; Cornelis E C A Hop; Anita Mathias; Yurong Lai; Mingxiang Liao; William G Humphreys; Sean C Kumer; Jashvant D Unadkat
Journal:  Drug Metab Dispos       Date:  2018-04-25       Impact factor: 3.922

5.  Activin A is a prominent autocrine regulator of hepatocyte growth arrest.

Authors:  Srividyameena Haridoss; Mladen I Yovchev; Hannah Schweizer; Sabreen Megherhi; Maria Beecher; Joseph Locker; Michael Oertel
Journal:  Hepatol Commun       Date:  2017-11-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.